» Articles » PMID: 37333015

Brief Report: A Multidisciplinary Initial Workup for Suspected Lung Cancer As Fast-Track Intervention to Histopathologic Diagnosis

Overview
Date 2023 Jun 19
PMID 37333015
Authors
Affiliations
Soon will be listed here.
Abstract

Guidelines for optimal timing of lung cancer diagnosis and treatment have been implemented in many countries, but the effect of fast-track interventions on the shortening of time interval is still debatable. In this study, the delay from the first specialist visit to the histopathologic diagnosis was compared between two patient cohorts: before (n = 280) and after (n = 247) implementation of a fast-track multidisciplinary diagnosis program. The cumulative incidence function curves were compared, and hazard ratio was adjusted in the Cox model. The implementation allowed a statistically significant increase in the cumulative incidence of the lung cancer histopathologic diagnosis over time. Adjusted hazard ratio for patients accrued in the post-implementation cohort was 1.22 (1.03-1.45) ( = 0.023), corresponding to a reduction of this waiting period by 18%. In conclusion, a multidisciplinary approach of the diagnostic process implemented at the initial visit allows a significant reduction of the timeline until the histopathologic diagnosis of lung cancer.

References
1.
Sainz Zuniga P, Ost D . Impact of Delays in Lung Cancer Treatment on Survival. Chest. 2021; 160(5):1934-1958. DOI: 10.1016/j.chest.2021.08.051. View

2.
Mullin M, Tran A, Golemiec B, Stone C, Noseworthy C, OCallaghan N . Improving Timeliness of Lung Cancer Diagnosis and Staging Investigations Through Implementation of Standardized Triage Pathways. JCO Oncol Pract. 2020; 16(10):e1202-e1208. PMC: 7564135. DOI: 10.1200/JOP.19.00807. View

3.
Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R . The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020; 21(8):1023-1034. PMC: 7417808. DOI: 10.1016/S1470-2045(20)30388-0. View

4.
Gomez D, Liao K, Swisher S, Blumenschein G, Erasmus Jr J, Buchholz T . Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol. 2015; 115(2):257-63. DOI: 10.1016/j.radonc.2015.04.010. View

5.
Moseholm E, Rydahl-Hansen S, Overgaard D, Wengel H, Frederiksen R, Brandt M . Health-related quality of life, anxiety and depression in the diagnostic phase of suspected cancer, and the influence of diagnosis. Health Qual Life Outcomes. 2016; 14:80. PMC: 4873991. DOI: 10.1186/s12955-016-0484-9. View